Loading…
How can we improve outcomes of chlamydia control programmes?
In Denmark, the incidence of gonorrhoea has been declining for years so gonococcal infection is not a likely candidate.6 However, Mycoplasma genitalium or ascendance of bacteria associated with bacterial vaginosis could be other candidates.7 But could the excess pelvic inflammatory disease risk asso...
Saved in:
| Published in: | The Lancet infectious diseases 2016-09, Vol.16 (9), p.989-990 |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c528t-94178444200c0027f6e9867671a4d67b015ca52d7d70f9237e2b389dcfa4d1d53 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c528t-94178444200c0027f6e9867671a4d67b015ca52d7d70f9237e2b389dcfa4d1d53 |
| container_end_page | 990 |
| container_issue | 9 |
| container_start_page | 989 |
| container_title | The Lancet infectious diseases |
| container_volume | 16 |
| creator | Schachter, Julius Chow, Joan M |
| description | In Denmark, the incidence of gonorrhoea has been declining for years so gonococcal infection is not a likely candidate.6 However, Mycoplasma genitalium or ascendance of bacteria associated with bacterial vaginosis could be other candidates.7 But could the excess pelvic inflammatory disease risk associated with chlamydia infection still be due to chlamydia infection despite its having been diagnosed and treated? Antigen detection methods used during 1995-2000 could have missed 50% of infections detectable by second-generation nucleic acid amplification tests available afterwards.9,10 Patients with pelvic inflammatory disease were once routinely admitted to hospital and diagnosis of ectopic pregnancy was determined surgically, but both transitioned predominantly to outpatient management.11 Because ascertainment of complications was based solely on hospital records, further work is needed to see if cohort members attended other primary care settings for milder presentations of complications. |
| doi_str_mv | 10.1016/S1473-3099(16)30131-1 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1825217937</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309916301311</els_id><sourcerecordid>4161798741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-94178444200c0027f6e9867671a4d67b015ca52d7d70f9237e2b389dcfa4d1d53</originalsourceid><addsrcrecordid>eNqNkV1rFTEQhoNY-v0TlAVv6sXWTD42GxCLlH4IBS-q1yEnmdXU3U1NdlvOvzfnbFXojUIgmcwz7zDvEPIK6ClQaN7dglC85lTrE2jecgocanhB9su3qIWQ6uX2vSB75CDnO0pBARW7ZI8p1mqu6T55fx0fK2fH6hGrMNyn-IBVnCcXB8xV7Cr3vbfD2gdbuThOKfZVYb4lO5T82RHZ6Wyf8fjpPiRfLy--nF_XN5-vPp1_vKmdZO1UawGqFUIwSh2lTHUN6rZRjQIrfKNWFKSzknnlFe004wrZirfau67kwUt-SE4W3dL754x5MkPIDvvejhjnbKBlkoHSXP0HCrLRrZZtQd88Q-_inMYyyIYSAng5hZIL5VLMOWFn7lMYbFoboGazCbPdhNnYbEq03YSBUvf6SX1eDej_VP22vgBnC4DFuYeAyWQXcHToQ0I3GR_DP1t8eKbg-jAGZ_sfuMb8dxqTmaGLyEYDmq0C8F9eVamb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1814413413</pqid></control><display><type>article</type><title>How can we improve outcomes of chlamydia control programmes?</title><source>ScienceDirect Freedom Collection</source><creator>Schachter, Julius ; Chow, Joan M</creator><creatorcontrib>Schachter, Julius ; Chow, Joan M</creatorcontrib><description>In Denmark, the incidence of gonorrhoea has been declining for years so gonococcal infection is not a likely candidate.6 However, Mycoplasma genitalium or ascendance of bacteria associated with bacterial vaginosis could be other candidates.7 But could the excess pelvic inflammatory disease risk associated with chlamydia infection still be due to chlamydia infection despite its having been diagnosed and treated? Antigen detection methods used during 1995-2000 could have missed 50% of infections detectable by second-generation nucleic acid amplification tests available afterwards.9,10 Patients with pelvic inflammatory disease were once routinely admitted to hospital and diagnosis of ectopic pregnancy was determined surgically, but both transitioned predominantly to outpatient management.11 Because ascertainment of complications was based solely on hospital records, further work is needed to see if cohort members attended other primary care settings for milder presentations of complications.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(16)30131-1</identifier><identifier>PMID: 27289390</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Bacterial infections ; Chlamydia ; Chlamydia Infections ; Chlamydia trachomatis ; Diagnostic tests ; Disease ; Health risks ; Hospitals ; Humans ; Infections ; Infectious Disease ; Infectious diseases ; Infertility ; Inflammatory diseases ; Mass Screening ; Nucleic acids ; Pregnancy complications ; Sexually transmitted diseases ; STD ; Womens health</subject><ispartof>The Lancet infectious diseases, 2016-09, Vol.16 (9), p.989-990</ispartof><rights>Schachter et al. Open Access article distributed under the terms of CC BY</rights><rights>2016 Schachter et al. Open Access article distributed under the terms of CC BY</rights><rights>Copyright Elsevier Limited Sep 01, 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-94178444200c0027f6e9867671a4d67b015ca52d7d70f9237e2b389dcfa4d1d53</citedby><cites>FETCH-LOGICAL-c528t-94178444200c0027f6e9867671a4d67b015ca52d7d70f9237e2b389dcfa4d1d53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27289390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schachter, Julius</creatorcontrib><creatorcontrib>Chow, Joan M</creatorcontrib><title>How can we improve outcomes of chlamydia control programmes?</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>In Denmark, the incidence of gonorrhoea has been declining for years so gonococcal infection is not a likely candidate.6 However, Mycoplasma genitalium or ascendance of bacteria associated with bacterial vaginosis could be other candidates.7 But could the excess pelvic inflammatory disease risk associated with chlamydia infection still be due to chlamydia infection despite its having been diagnosed and treated? Antigen detection methods used during 1995-2000 could have missed 50% of infections detectable by second-generation nucleic acid amplification tests available afterwards.9,10 Patients with pelvic inflammatory disease were once routinely admitted to hospital and diagnosis of ectopic pregnancy was determined surgically, but both transitioned predominantly to outpatient management.11 Because ascertainment of complications was based solely on hospital records, further work is needed to see if cohort members attended other primary care settings for milder presentations of complications.</description><subject>Bacterial infections</subject><subject>Chlamydia</subject><subject>Chlamydia Infections</subject><subject>Chlamydia trachomatis</subject><subject>Diagnostic tests</subject><subject>Disease</subject><subject>Health risks</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Infertility</subject><subject>Inflammatory diseases</subject><subject>Mass Screening</subject><subject>Nucleic acids</subject><subject>Pregnancy complications</subject><subject>Sexually transmitted diseases</subject><subject>STD</subject><subject>Womens health</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkV1rFTEQhoNY-v0TlAVv6sXWTD42GxCLlH4IBS-q1yEnmdXU3U1NdlvOvzfnbFXojUIgmcwz7zDvEPIK6ClQaN7dglC85lTrE2jecgocanhB9su3qIWQ6uX2vSB75CDnO0pBARW7ZI8p1mqu6T55fx0fK2fH6hGrMNyn-IBVnCcXB8xV7Cr3vbfD2gdbuThOKfZVYb4lO5T82RHZ6Wyf8fjpPiRfLy--nF_XN5-vPp1_vKmdZO1UawGqFUIwSh2lTHUN6rZRjQIrfKNWFKSzknnlFe004wrZirfau67kwUt-SE4W3dL754x5MkPIDvvejhjnbKBlkoHSXP0HCrLRrZZtQd88Q-_inMYyyIYSAng5hZIL5VLMOWFn7lMYbFoboGazCbPdhNnYbEq03YSBUvf6SX1eDej_VP22vgBnC4DFuYeAyWQXcHToQ0I3GR_DP1t8eKbg-jAGZ_sfuMb8dxqTmaGLyEYDmq0C8F9eVamb</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Schachter, Julius</creator><creator>Chow, Joan M</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20160901</creationdate><title>How can we improve outcomes of chlamydia control programmes?</title><author>Schachter, Julius ; Chow, Joan M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-94178444200c0027f6e9867671a4d67b015ca52d7d70f9237e2b389dcfa4d1d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Bacterial infections</topic><topic>Chlamydia</topic><topic>Chlamydia Infections</topic><topic>Chlamydia trachomatis</topic><topic>Diagnostic tests</topic><topic>Disease</topic><topic>Health risks</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Infertility</topic><topic>Inflammatory diseases</topic><topic>Mass Screening</topic><topic>Nucleic acids</topic><topic>Pregnancy complications</topic><topic>Sexually transmitted diseases</topic><topic>STD</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schachter, Julius</creatorcontrib><creatorcontrib>Chow, Joan M</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schachter, Julius</au><au>Chow, Joan M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>How can we improve outcomes of chlamydia control programmes?</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>16</volume><issue>9</issue><spage>989</spage><epage>990</epage><pages>989-990</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>In Denmark, the incidence of gonorrhoea has been declining for years so gonococcal infection is not a likely candidate.6 However, Mycoplasma genitalium or ascendance of bacteria associated with bacterial vaginosis could be other candidates.7 But could the excess pelvic inflammatory disease risk associated with chlamydia infection still be due to chlamydia infection despite its having been diagnosed and treated? Antigen detection methods used during 1995-2000 could have missed 50% of infections detectable by second-generation nucleic acid amplification tests available afterwards.9,10 Patients with pelvic inflammatory disease were once routinely admitted to hospital and diagnosis of ectopic pregnancy was determined surgically, but both transitioned predominantly to outpatient management.11 Because ascertainment of complications was based solely on hospital records, further work is needed to see if cohort members attended other primary care settings for milder presentations of complications.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>27289390</pmid><doi>10.1016/S1473-3099(16)30131-1</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1473-3099 |
| ispartof | The Lancet infectious diseases, 2016-09, Vol.16 (9), p.989-990 |
| issn | 1473-3099 1474-4457 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1825217937 |
| source | ScienceDirect Freedom Collection |
| subjects | Bacterial infections Chlamydia Chlamydia Infections Chlamydia trachomatis Diagnostic tests Disease Health risks Hospitals Humans Infections Infectious Disease Infectious diseases Infertility Inflammatory diseases Mass Screening Nucleic acids Pregnancy complications Sexually transmitted diseases STD Womens health |
| title | How can we improve outcomes of chlamydia control programmes? |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T23%3A24%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=How%20can%20we%20improve%20outcomes%20of%20chlamydia%20control%20programmes?&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Schachter,%20Julius&rft.date=2016-09-01&rft.volume=16&rft.issue=9&rft.spage=989&rft.epage=990&rft.pages=989-990&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(16)30131-1&rft_dat=%3Cproquest_cross%3E4161798741%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c528t-94178444200c0027f6e9867671a4d67b015ca52d7d70f9237e2b389dcfa4d1d53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1814413413&rft_id=info:pmid/27289390&rfr_iscdi=true |